Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/CAPLIPOINT stock hub

NSE/CAPLIPOINT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/CAPLIPOINTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

141.2B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/CAPLIPOINT

In the news

Latest news · NSE/CAPLIPOINT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.9

P25 24.9P50 32.4P75 45.7

Trailing P/E23

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC24.5

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/CAPLIPOINT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

INR

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	3,966
Employees Change	560%
Employees Change Percent	16.44
Enterprise value	INR 132.2B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE475E01026
Last refreshed	2026-05-10
Market cap	INR 141.2B
Price	INR 1,854
Price currency	INR
Rev Per Employee	5,273,777.11x
Sector	Healthcare
Sic	2834
Symbol	nse/CAPLIPOINT
Website	https://www.caplinpoint.net

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.35%
EV Earnings	21.54x
EV/EBIT	20.04x
EV/EBITDA	18.07x
EV/Sales	6.32x
Forward P/E	20.89x
P/B ratio	4.41x
P/E ratio	23x
P/S ratio	6.75x
PE Ratio10 Y	22.3x
PE Ratio3 Y	23.87x
PE Ratio5 Y	21.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.54%
EBITDA Margin	34.92%
Gross margin	59.23%
Gross Profit	INR 12.4B
Gross Profit Growth	12.9%
Gross Profit Growth Q	10.09%
Gross Profit Growth3 Y	17.44%
Gross Profit Growth5 Y	18.66%
Net Income	INR 6.1B
Net Income Growth	19.09%
Net Income Growth Q	17.93%
Net Income Growth Quarters	21%
Net Income Growth Years	17%
Net Income Growth3 Y	20.22%
Net Income Growth5 Y	22.25%
Pretax Margin	36.62%
Profit Margin	29.34%
Profit Per Employee	INR 1.5M
Profitable Years	19
Roa5y	13.35
Roe5y	22.09
ROIC	24.5
Roic5y	29.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	26.21%
Cagr1y	-0.18%
Cagr3y	40.4%
Cagr5y	26.79%
Div CAGR10	12.79%
Div CAGR3	14.47%
Div CAGR5	19.14%
EPS Growth	19.36
EPS Growth Q	18.25
EPS Growth Quarters	21
EPS Growth Years	17
EPS Growth3 Y	20.34
EPS Growth5 Y	22.25
Revenue Growth	10.65x
Revenue Growth Q	10.1x
Revenue Growth Quarters	54x
Revenue Growth Years	16x
Revenue Growth3 Y	13.83x
Revenue Growth5 Y	15.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 10.2B
Debt	INR 53.1M
Debt EBITDA	INR 0.01
Debt Equity	INR 0
Equity	INR 32B
Interest Coverage	970.2
Net Cash	INR 10.1B
Net Cash By Market Cap	INR 7.17
Net Cash Growth	22.77%
Net Debt EBITDA	INR -1.39
Net Debt Equity	INR -0.32
Tangible Book Value	INR 30.6B
Tangible Book Value Per Share	INR 402
WACC	5.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.22%
Dividend Growth	20%
Dividend Growth Years	12%
Dividend per share	INR 6
Dividend Years	12
Dividend Yield	0.32%
Ex Div Date	2025-09-12
Last Dividend	INR 3

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	924.95%
1Y total return	-0.18%
200-day SMA	1,907.8
3Y total return	176.83%
50-day SMA	1,685.9
50-day SMA vs 200-day SMA	50under200
5Y total return	227.63%
All Time High	2,641
All Time High Change	-29.8%
All Time High Date	2024-12-27
All Time Low	34.2
All Time Low Change	5,321.05%
All Time Low Date	2014-06-23
ATR	49.35
Beta	0.16
Ch YTD	0.87
High	1,870.6
High52	2,395
High52 Date	2025-09-17
High52ch	-22.59%
Low	1,845.5
Low52	1,500.3
Low52 Date	2026-03-30
Low52ch	23.58%
Ma50ch	9.97%
Price vs 200-day SMA	-2.82%
RSI	67.45
RSI Monthly	53.54
RSI Weekly	53.22
Sharpe ratio	-0.01x
Sortino ratio	0.17
Total Return	0.55%
Tr YTD	0.87
Tr1m	15.12%
Tr1w	6.78%
Tr3m	1.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 6.6B
Operating Income Growth	17.45
Operating Income Growth Q	16.65
Operating Income Growth3 Y	20.87
Operating Income Growth5 Y	20.28
Operating margin	31.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,256,746%
Shares Insiders	67.61%
Shares Institutions	6.17%
Shares Qo Q	-0.11%
Shares Yo Y	-0.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	95,409.85x
Bv Per Share	405.8
Ch10y	882.7
Ch1m	15.12
Ch1w	6.78
Ch1y	-0.46
Ch3m	1.55
Ch3y	173.8
Ch5y	221
Ch6m	-4.06
Change	-0.68%
Change From Open	-0.86
Close	1,866.6
Days Gap	0.18
Depreciation Amortization	705,800,000
Dollar Volume	100,955,862
Earnings Date	2026-05-14
EBIT	INR 6.6B
EBITDA	INR 7.3B
EPS	INR 80.5
F Score	2
Fiscal Year End	March
Founded	1,990
Graham Number	872.79313
Graham Upside	-52.92
Income Tax	INR 1.4B
Is Primary Listing	0
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Last Split Date	2016-10-19
Last Split Type	Forward
Lynch Fair Value	INR 1,793
Lynch Upside	-3.3
Ma150	1,829.2
Ma150ch	1.36%
Ma20	1,752.2
Ma20ch	5.81%
Next Earnings Date	2026-05-14
Open	1,870
Payment Date	2025-10-21
Position In Range	33.86
Price Date	2026-05-08
Price EBITDA	INR 19.33
Ptbv Ratio	4.62
Relative Volume	0.54x
Revenue	20,915,800,000x
Tax By Revenue	6.88x
Tax Rate	18.78%
Tr6m	-4.06%
Volume	54,453

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/CAPLIPOINT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$6.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+19.1%

12 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2025-09-12

Performance

NSE/CAPLIPOINT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/CAPLIPOINT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.2%

Share of float held by funds and institutions

Insider ownership

+67.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

NSE/CAPLIPOINT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.5

Neutral momentum band

Price vs 200-day MA

-2.8%

50/200-day relationship not available

Beta (5Y)

0.16

Less volatile than the market

Sharpe ratio

-0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/CAPLIPOINT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/CAPLIPOINT stock rating?

nse/CAPLIPOINT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/CAPLIPOINT analysis?

The full report lives at /stocks/nse/CAPLIPOINT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/CAPLIPOINT?

The latest report frames nse/CAPLIPOINT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/CAPLIPOINT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.